Can you imagine the NETFLIX Movie: "The Bottom of America's Swamp"
Can you imagine, if at the end of April 2020, the FDA had been "clean" and had merely followed their own criteria for granting EUAs, based upon Leronlimab's pristine proven safety from 800+ HIV patients, and Leronlimab's displayed covid-19 efficacy in eIND cases, then add Dr Patterson's early 2020 Ted talk?
FDA criteria for an EUA, if a drug "may be effective" and is proven to be safe" an EUA can be granted. OK, we are in a frightening global pandemic. EUA? No....
Can you imagine, the deaths? Can you imagine the depth of this scandal?
The FDA says no, to 4 doses in our s/c trial protocal design, when data was easily accessible, that Dr Patterson had given 3 and/or 4 doses to critical patients in our hugely successful early 2020 eIND cv19 patients! Not 2 doses, not 1 dose, not 5 doses, not IV dosages, not 8 dose, but 3 or 4.
Our m/m trial yields Clinical Significance for the Primary Endpoint and Statistical Significance for Secondary Endpoint, pristine safety...We are in a frightening global pandemic. EUA?....No
Our s/c trial yields 24% reduction in critical deaths vs SOC and 31.8% reduction in critical deaths vs SOC for ages 65 and younger. OK, we are in a frightening global pandemic. EUA?.....No
Our s/c trials yields 82% reduction in deaths vs SOC at 14 days. OK, we are in a frightening pandemic. EUA?.....No
Remdesivir, plasma, hydroxychloroquine, Eli Lilly, Regeneron?????
Can you imagine, if at the end of April 2020, the FDA had been "clean" and had merely followed their own criteria for granting EUAs, based upon Leronlimab's pristine proven safety from 800+ HIV patients, and Leronlimab's displayed covid-19 efficacy in eIND cases, then add Dr Patterson's early 2020 Ted talk?
FDA criteria for an EUA, if a drug "may be effective" and is proven to be safe" an EUA can be granted. OK, we are in a frightening global pandemic. EUA? No....
Can you imagine, the deaths? Can you imagine the depth of this scandal?
The FDA says no, to 4 doses in our s/c trial protocal design, when data was easily accessible, that Dr Patterson had given 3 and/or 4 doses to critical patients in our hugely successful early 2020 eIND cv19 patients! Not 2 doses, not 1 dose, not 5 doses, not IV dosages, not 8 dose, but 3 or 4.
Our m/m trial yields Clinical Significance for the Primary Endpoint and Statistical Significance for Secondary Endpoint, pristine safety...We are in a frightening global pandemic. EUA?....No
Our s/c trial yields 24% reduction in critical deaths vs SOC and 31.8% reduction in critical deaths vs SOC for ages 65 and younger. OK, we are in a frightening global pandemic. EUA?.....No
Our s/c trials yields 82% reduction in deaths vs SOC at 14 days. OK, we are in a frightening pandemic. EUA?.....No
Remdesivir, plasma, hydroxychloroquine, Eli Lilly, Regeneron?????
12
